Buy CLOMIPHENE CITRATE Online

$21.85

CHARACTERISTICS
ACTIVE HALF-LIFE 5-7 DAYS
CLASSIFICATION SERM
DOSAGE 50-100 MG/DAY
ACNE NO
WATER RETENTION NO
HBR RARE
HEPATOTOXICITY LOW
AROMATIZATION NO
ACTIVE SUBSTANCE CLOMIPHENE CITRATE
FORM 50 PILLS X 50 MG
MANUFACTURER HILMA BIOCARE

-
+
Compare

Description

Chemical name: 2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]-~{N},~{N}-diethylethanamine
Formula: C26H28ClNO
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid

CLOMIPHENE CITRATE 50mg – HILMA BIOCARE

Clomiphene citrate is a selective estrogen receptor modulator (SERM) that is commonly used in the world of bodybuilding and athletics. It is a synthetic compound that works by blocking estrogen receptors in the body, which can help to increase the production of testosterone and other hormones.

One of the key characteristics of clomiphene citrate is its active half-life of 5-7 days. This means that it stays active in the body for a relatively long period of time, which can be beneficial for athletes who are looking to maintain a consistent level of hormone production.

The recommended dosage for clomiphene citrate is typically between 50-100 mg per day, depending on the individual’s goals and tolerance. It is available in a convenient pill form, with each bottle containing 50 pills that are 50 mg each.

One of the major benefits of clomiphene citrate is that it does not cause acne or water retention. While it may cause HBR in rare cases, the likelihood of this side effect is relatively low. Additionally, clomiphene citrate is not associated with hepatotoxicity or aromatization.

Clomiphene citrate is manufactured by Hilma Biocare, a reputable name in the pharmaceutical industry. As with any medication, it is important to follow the recommended dosage and seek medical advice before using Clomiphene citrate to ensure that it is safe and effective for your individual needs.

Reviews

There are no reviews yet.

Be the first to review “Buy CLOMIPHENE CITRATE Online”

Your email address will not be published. Required fields are marked *